Page last updated: 2024-11-05

3,5-dimethylpyridine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

3,5-Dimethylpyridine, also known as 2,6-lutidine, is a heterocyclic organic compound with the formula C7H9N. It is a colorless liquid with a characteristic pyridine-like odor. This compound is an important intermediate in the synthesis of pharmaceuticals, agrochemicals, and other fine chemicals. 3,5-Dimethylpyridine is a valuable starting material for the synthesis of various pharmaceuticals, including anti-inflammatory drugs, anticonvulsants, and anti-cancer agents. It has also been investigated for its potential applications in the synthesis of pesticides, herbicides, and fungicides. The compound's ability to act as a ligand in coordination chemistry is another area of research interest, as it can form complexes with various metal ions, leading to the development of new catalysts and materials.'

Cross-References

ID SourceID
PubMed CID11565
SCHEMBL ID24225
MeSH IDM0511840

Synonyms (37)

Synonym
AC-15531
einecs 209-708-6
ec 209-708-6
unii-6q4ypz045v
nsc 60736
6q4ypz045v ,
nsc60736
nsc-60736
3,5-lutidine
3,5-dimethylpyridine
591-22-0
inchi=1/c7h9n/c1-6-3-7(2)5-8-4-6/h3-5h,1-2h
pyridine, 3,5-dimethyl-
3,5-lutidine, >=98%
NCIOPEN2_004681
L0068
A832172
EN300-82871
3,5-dimethyl-pyridine
3,5-dimethyl pyridine
STL280373
AKOS015891741
3,5 lutidine
AM81286
SCHEMBL24225
dtxsid5052254 ,
tox21_303943
dtxcid0030825
cas-591-22-0
NCGC00357179-01
W-105339
3,5-lutdcine
mfcd00006404
F0001-1549
3,5-lutidine, analytical standard
BCP26361
Q23636070
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency27.85120.001530.607315,848.9004AID1224841; AID1224849
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.84

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.84 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.73 (4.65)
Search Engine Demand Index40.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.84)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]